Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 1
2007 2
2008 3
2009 10
2010 7
2011 7
2012 9
2013 5
2014 9
2015 9
2016 5
2017 5
2018 2
2019 2
2020 5
2021 5
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
Cixutumumab.
McKian KP, Haluska P. McKian KP, et al. Among authors: haluska p. Expert Opin Investig Drugs. 2009 Jul;18(7):1025-33. doi: 10.1517/13543780903055049. Expert Opin Investig Drugs. 2009. PMID: 19548856 Free PMC article. Review.
Patient-derived xenograft models in gynecologic malignancies.
Scott CL, Mackay HJ, Haluska P Jr. Scott CL, et al. Among authors: haluska p jr. Am Soc Clin Oncol Educ Book. 2014:e258-66. doi: 10.14694/EdBook_AM.2014.34.e258. Am Soc Clin Oncol Educ Book. 2014. PMID: 24857111 Free PMC article. Review.
The insulin-like growth factor system in cancer.
Weroha SJ, Haluska P. Weroha SJ, et al. Among authors: haluska p. Endocrinol Metab Clin North Am. 2012 Jun;41(2):335-50, vi. doi: 10.1016/j.ecl.2012.04.014. Endocrinol Metab Clin North Am. 2012. PMID: 22682634 Free PMC article. Review.
Developing safety criteria for introducing new agents into neoadjuvant trials.
DeMichele A, Berry DA, Zujewski J, Hunsberger S, Rubinstein L, Tomaszewski JE, Kelloff G, Perlmutter J, Buxton M, Lyandres J, Albain KS, Benz C, Chien AJ, Haluska P, Leyland-Jones B, Liu MC, Munster P, Olopade O, Park JW, Parker BA, Pusztai L, Tripathy D, Rugo H, Yee D, Esserman L. DeMichele A, et al. Among authors: haluska p. Clin Cancer Res. 2013 Jun 1;19(11):2817-23. doi: 10.1158/1078-0432.CCR-12-2620. Epub 2013 Mar 7. Clin Cancer Res. 2013. PMID: 23470967 Free PMC article. Review.
Hormone response in ovarian cancer: time to reconsider as a clinical target?
Modugno F, Laskey R, Smith AL, Andersen CL, Haluska P, Oesterreich S. Modugno F, et al. Among authors: haluska p. Endocr Relat Cancer. 2012 Nov 9;19(6):R255-79. doi: 10.1530/ERC-12-0175. Print 2012 Dec. Endocr Relat Cancer. 2012. PMID: 23045324 Free PMC article. Review.
Can we unlock the potential of IGF-1R inhibition in cancer therapy?
King H, Aleksic T, Haluska P, Macaulay VM. King H, et al. Among authors: haluska p. Cancer Treat Rev. 2014 Oct;40(9):1096-105. doi: 10.1016/j.ctrv.2014.07.004. Epub 2014 Aug 4. Cancer Treat Rev. 2014. PMID: 25123819 Free PMC article. Review.
Malignant melanoma in the 21st century: the emerging molecular landscape.
Sekulic A, Haluska P Jr, Miller AJ, Genebriera De Lamo J, Ejadi S, Pulido JS, Salomao DR, Thorland EC, Vile RG, Swanson DL, Pockaj BA, Laman SD, Pittelkow MR, Markovic SN; Melanoma Study Group of Mayo Clinic Cancer Center. Sekulic A, et al. Among authors: haluska p jr. Mayo Clin Proc. 2008 Jul;83(7):825-46. doi: 10.4065/83.7.825. Mayo Clin Proc. 2008. PMID: 18613999 Free PMC article. Review.
76 results